Cancer diagnostics company iCellate Medical AB announces collaboration with football star Olivia Schough. Olivia shares her story of hereditary cancer…
February 10, 2022. Elthera AG, iCellate Medical AB, Targos Molecular Pathology GmbH and Prof. Dr. Susanne Sebens at the Institute of Experimental…
Changes in our DNA occur all of the time. Many are harmless, while others cause disease.
What is the likelihood that you carry a pathogenic variant?
The importance of family cancer history and how to map it
Stomach cancer is the fifth most common cancer in the world, and 10-20% is hereditary
Increased visibility of hereditary cancer risk can lead to increased opportunities for cancer prevention and early detection
Come join us!
All first-degree relatives of a carrier have a 50% risk of themselves being a carrier
Melanoma is the most rapidly increasing cancer in Sweden and 10-15% of all cases are hereditary
Our clinically actionable selection of genes gives you a better shot at prevention.
1 in 5 Swedish men will be diagnosed with prostate cancer. Guidelines for the identification of hereditary prostate cancer are now expanded.
Family history-based testing identifies some, misses many
Polyposis' cause, associated cancer types, and risk-reducing measures
iCellate is the only Swedish company that holds an ISO 15189 certification within cancer diagnostics.
15-20% of all ovarian cancer is hereditary
Lynch syndrom is caused by hereditary pathogenic variants and increases the risk of several different cancer types
15-20% of all breast cancer is hereditary
One third of all colorectal cancer is hereditary